Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China
· Delayed Price · Currency is CNY 11.74
+0.05 (0.43%)
At close: Apr 29, 2026
SHE:301126 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -225.93 | -228.75 | 26.57 | 34.3 | 51.08 | 68.26 | Upgrade
|
| Depreciation & Amortization | 156.49 | 156.49 | 145.96 | 83.44 | 42.28 | 22.68 | Upgrade
|
| Other Amortization | 19.83 | 19.83 | 23.39 | 16.14 | 9.1 | 3.33 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.81 | -1.81 | -1.38 | -1.11 | -0.32 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 210.98 | 210.98 | 12.67 | 0.48 | 0.01 | 13.52 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.67 | -1.67 | -0.03 | -1.24 | -0.32 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 7.88 | 14.92 | 16.74 | - | Upgrade
|
| Other Operating Activities | 247.06 | 116.47 | 134.42 | 87.39 | 47.37 | 34.96 | Upgrade
|
| Change in Accounts Receivable | -388.47 | -388.47 | -337.18 | -164.94 | -374.6 | -438.62 | Upgrade
|
| Change in Inventory | -44.3 | -44.3 | -51.3 | -116.38 | -125.59 | 36.29 | Upgrade
|
| Change in Accounts Payable | 50.73 | 50.73 | 136.15 | 99.6 | -156.91 | 115.04 | Upgrade
|
| Change in Other Net Operating Assets | -19.51 | -19.51 | -63.39 | -13.87 | 0.86 | -15.14 | Upgrade
|
| Operating Cash Flow | -15.71 | -149.12 | 24.04 | 27.13 | -493.96 | -161.81 | Upgrade
|
| Operating Cash Flow Growth | - | - | -11.39% | - | - | - | Upgrade
|
| Capital Expenditures | -93.46 | -104.63 | -187.14 | -226.7 | -208.73 | -33.29 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.18 | 0.18 | 1.28 | 0.22 | 0.08 | - | Upgrade
|
| Cash Acquisitions | -109.53 | -109.53 | -496.86 | -412.22 | -127.74 | - | Upgrade
|
| Investment in Securities | 49.51 | - | 25.5 | 41.1 | -120 | - | Upgrade
|
| Other Investing Activities | -6.76 | -6.83 | -30.77 | -201.25 | -47.96 | - | Upgrade
|
| Investing Cash Flow | -160.06 | -220.81 | -687.98 | -798.84 | -504.34 | -33.29 | Upgrade
|
| Long-Term Debt Issued | - | 2,663 | 2,668 | 2,351 | 1,608 | 819.64 | Upgrade
|
| Long-Term Debt Repaid | - | -2,487 | -1,994 | -1,382 | -780.55 | -788.91 | Upgrade
|
| Total Debt Repaid | -2,472 | -2,487 | -1,994 | -1,382 | -780.55 | -788.91 | Upgrade
|
| Net Debt Issued (Repaid) | 120.89 | 176.25 | 674.01 | 968.66 | 827.08 | 30.73 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.49 | 596.17 | Upgrade
|
| Repurchase of Common Stock | -0.1 | - | -10.01 | - | - | - | Upgrade
|
| Common Dividends Paid | -109.93 | -111.99 | -92.35 | -72.45 | -41.22 | -30.97 | Upgrade
|
| Dividends Paid | -109.93 | -111.99 | -92.35 | -72.45 | -41.22 | -30.97 | Upgrade
|
| Other Financing Activities | -15.46 | 39.7 | -0.65 | -31.74 | - | 102.9 | Upgrade
|
| Financing Cash Flow | -4.61 | 103.96 | 571 | 864.47 | 786.34 | 698.83 | Upgrade
|
| Net Cash Flow | -180.37 | -265.97 | -92.94 | 92.76 | -211.96 | 503.73 | Upgrade
|
| Free Cash Flow | -109.17 | -253.75 | -163.1 | -199.57 | -702.69 | -195.1 | Upgrade
|
| Free Cash Flow Margin | -2.09% | -4.93% | -3.12% | -5.11% | -21.34% | -7.53% | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -1.24 | -0.80 | -0.99 | -3.44 | -1.26 | Upgrade
|
| Cash Income Tax Paid | 150.65 | 156.56 | 129.84 | 99.43 | 88.67 | 80.45 | Upgrade
|
| Levered Free Cash Flow | -40.6 | -134.3 | -271.24 | 27.05 | -643.98 | -59.8 | Upgrade
|
| Unlevered Free Cash Flow | -40.6 | -134.3 | -203.85 | 70.5 | -618.51 | -38 | Upgrade
|
| Change in Working Capital | -420.66 | -420.66 | -325.42 | -207.19 | -659.91 | -304.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.